OAM
ACH

Oppenheimer Asset Management’s Accendra Health ACH Stock Holding History

Oppenheimer Asset Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,583
Closed -$400K – 1169
2022
Q3 		$400K Sell
16,583
-402
-2% -$12.4K 0.01% 885
2022
Q2 		$534K Buy
+16,985
New +$615K 0.01% 834

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oppenheimer Asset Management's ACH Position: Q4 2022 in Review

Oppenheimer Asset Management sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 16,583 shares — an estimated $400K sold.

Oppenheimer Asset Management first reported a position in ACH in Q2 2022 and held it in 2 quarters. The position peaked at $534K in Q2 2022. 219 funds tracked by Wall St. Rank hold ACH as of Q4 2022.

  • Oppenheimer Asset Management reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
  • Oppenheimer Asset Management sold 16,583 Accendra Health shares in Q4 2022, an estimated $400K.
  • Oppenheimer Asset Management first reported a position in Accendra Health in Q2 2022 and held it in 2 quarters.
  • Oppenheimer Asset Management's Accendra Health position peaked at $534K in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.

Based on Oppenheimer Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.